ketamine has been researched along with Vascular Diseases in 3 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study aims to evaluate the efficacy and safety of subdissociative intranasal ketamine as a cheap, readily available and easily administered adjunct to standard pain therapy." | 9.24 | Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial. ( Helm, E; Mfinanga, JA; Moore, CG; Nshom, E; Reynolds, SL; Runyon, MS; Sawe, HR; Young, JR, 2017) |
| " This study aims to evaluate the efficacy and safety of subdissociative intranasal ketamine as a cheap, readily available and easily administered adjunct to standard pain therapy." | 5.24 | Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial. ( Helm, E; Mfinanga, JA; Moore, CG; Nshom, E; Reynolds, SL; Runyon, MS; Sawe, HR; Young, JR, 2017) |
| " Outcomes studied included impact on opioid analgesic use, a description of ketamine dosing strategy, and an analysis of adverse events due to opioid or ketamine analgesia." | 1.48 | Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series. ( Boylan, A; Floroff, C; Hassig, TB; Kanter, J; Palm, N, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Young, JR | 1 |
| Sawe, HR | 1 |
| Mfinanga, JA | 1 |
| Nshom, E | 1 |
| Helm, E | 1 |
| Moore, CG | 1 |
| Runyon, MS | 1 |
| Reynolds, SL | 1 |
| Palm, N | 1 |
| Floroff, C | 1 |
| Hassig, TB | 1 |
| Boylan, A | 1 |
| Kanter, J | 1 |
| Venturini, AH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Sub-dissociative Intranasal Ketamine Plus Standard Pain Therapy Versus Standard Pain Therapy in the Treatment of Pediatric Sickle Cell Disease Vasoocclusive Crises in Resource-limited Settings: a Multi-centered, Randomized, Controlled Trial[NCT02573714] | 160 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ketamine and Vascular Diseases
| Article | Year |
|---|---|
Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial.
Topics: Administration, Intranasal; Adolescent; Analgesics; Anemia, Sickle Cell; Cameroon; Child; Child, Pre | 2017 |
2 other studies available for ketamine and Vascular Diseases
| Article | Year |
|---|---|
Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
Topics: Adult; Analgesics; Analgesics, Opioid; Anemia, Sickle Cell; Dose-Response Relationship, Drug; Female | 2018 |
[Control of psychomimetric reacitons of ketamine using RO 5-4200/613].
Topics: Adult; Aged; Anesthesia; Atropine; Benzodiazepines; Central Nervous System; Drug Evaluation; Female; | 1975 |